Sugar-Sweetened Beverage Consumption and Plasma Lipoprotein Cholesterol, Apolipoprotein, and Lipoprotein Particle Size Concentrations in US Adults

Prospective cohort studies have found a relation between sugar-sweetened beverage (SSB) consumption (sodas and fruit drinks) and dyslipidemia. There is limited evidence linking SSB consumption to emerging features of dyslipidemia, which can be characterized by variation in lipoprotein particle size,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of nutrition 2022-11, Vol.152 (11), p.2534
Hauptverfasser: Haslam, Danielle E, Chasman, Daniel I, Peloso, Gina M, Herman, Mark A, Dupuis, Josée, Lichtenstein, Alice H, Smith, Caren E, Ridker, Paul M, Jacques, Paul F, Mora, Samia, McKeown, Nicola M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 11
container_start_page 2534
container_title The Journal of nutrition
container_volume 152
creator Haslam, Danielle E
Chasman, Daniel I
Peloso, Gina M
Herman, Mark A
Dupuis, Josée
Lichtenstein, Alice H
Smith, Caren E
Ridker, Paul M
Jacques, Paul F
Mora, Samia
McKeown, Nicola M
description Prospective cohort studies have found a relation between sugar-sweetened beverage (SSB) consumption (sodas and fruit drinks) and dyslipidemia. There is limited evidence linking SSB consumption to emerging features of dyslipidemia, which can be characterized by variation in lipoprotein particle size, remnant-like particle (RLP), and apolipoprotein concentrations. To examine the association between SSB consumption and plasma lipoprotein cholesterol, apolipoprotein, and lipoprotein particle size concentrations among US adults. We examined participants from the Framingham Offspring Study (FOS; 1987-1995, n = 3047) and the Women's Health Study (1992, n = 26,218). Concentrations of plasma LDL cholesterol, apolipoprotein B (apoB), HDL cholesterol, apolipoprotein A1 (apoA1), triglyceride (TG), and non-HDL cholesterol, as well as total cholesterol:HDL cholesterol ratio and apoB:apoA1 ratio, were quantified in both cohorts; concentrations of apolipoprotein E, apolipoprotein C3, RLP-TG, and RLP cholesterol (RLP-C) were measured in the FOS only. Lipoprotein particle sizes were calculated from nuclear magnetic resonance signals for lipoprotein particle subclass concentrations (TG-rich lipoprotein particles [TRL-Ps]: very large, large, medium, small, and very small; LDL particles [LDL-Ps]: large, medium, and small; HDL particles [HDL-Ps]: large, medium, and small). SSB consumption was estimated from food frequency questionnaire data. We examined the associations between SSB consumption and all lipoprotein and apoprotein measures in linear regression models, adjusting for confounding factors such as lifestyle, diet, and traditional lipoprotein risk factors. SSB consumption was positively associated with LDL cholesterol, apoB, TG, RLP-TG, RLP-C, and non-HDL cholesterol concentrations and total cholesterol:HDL cholesterol and apoB:apoA1 ratios; and negatively associated with HDL cholesterol and apoA1 concentrations (P-trend range:
doi_str_mv 10.1093/jn/nxac166
format Article
fullrecord <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_36774119</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>36774119</sourcerecordid><originalsourceid>FETCH-LOGICAL-p108t-bd8fae66b17412d16fbed9a2e27597cc12738b39e9b01f0455d6f027d0996d5c3</originalsourceid><addsrcrecordid>eNpNkEtOwzAYhC0kREthwwGQD9BQOw8nXpaIAlIlKoWuKyf-U1I5tmU7vI7BiSkFBKtZzMwnzSB0QckVJTyZ7fRMv4qGMnaExjRLacQoISN06v2OEEJTXpygUcLyPKWUj9FHNWyFi6oXgAAaJL6GZ3BiC7g02g-9DZ3RWGiJV0r4XuBlZ411JkCncflkFPgAzqgpnluj_rzpofM_vBIudI0CXHXvB3oDOjjxxfd4768rPJeDCv4MHbdCeTj_0QlaL24ey7to-XB7X86XkaWkCFEti1YAYzXdT4klZW0NkosY4jzjedPQOE-KOuHAa0JbkmaZZC2Jc0k4ZzJrkgm6_Obaoe5BbqzreuHeNr_nJJ9SImgD</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Sugar-Sweetened Beverage Consumption and Plasma Lipoprotein Cholesterol, Apolipoprotein, and Lipoprotein Particle Size Concentrations in US Adults</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Haslam, Danielle E ; Chasman, Daniel I ; Peloso, Gina M ; Herman, Mark A ; Dupuis, Josée ; Lichtenstein, Alice H ; Smith, Caren E ; Ridker, Paul M ; Jacques, Paul F ; Mora, Samia ; McKeown, Nicola M</creator><creatorcontrib>Haslam, Danielle E ; Chasman, Daniel I ; Peloso, Gina M ; Herman, Mark A ; Dupuis, Josée ; Lichtenstein, Alice H ; Smith, Caren E ; Ridker, Paul M ; Jacques, Paul F ; Mora, Samia ; McKeown, Nicola M</creatorcontrib><description>Prospective cohort studies have found a relation between sugar-sweetened beverage (SSB) consumption (sodas and fruit drinks) and dyslipidemia. There is limited evidence linking SSB consumption to emerging features of dyslipidemia, which can be characterized by variation in lipoprotein particle size, remnant-like particle (RLP), and apolipoprotein concentrations. To examine the association between SSB consumption and plasma lipoprotein cholesterol, apolipoprotein, and lipoprotein particle size concentrations among US adults. We examined participants from the Framingham Offspring Study (FOS; 1987-1995, n = 3047) and the Women's Health Study (1992, n = 26,218). Concentrations of plasma LDL cholesterol, apolipoprotein B (apoB), HDL cholesterol, apolipoprotein A1 (apoA1), triglyceride (TG), and non-HDL cholesterol, as well as total cholesterol:HDL cholesterol ratio and apoB:apoA1 ratio, were quantified in both cohorts; concentrations of apolipoprotein E, apolipoprotein C3, RLP-TG, and RLP cholesterol (RLP-C) were measured in the FOS only. Lipoprotein particle sizes were calculated from nuclear magnetic resonance signals for lipoprotein particle subclass concentrations (TG-rich lipoprotein particles [TRL-Ps]: very large, large, medium, small, and very small; LDL particles [LDL-Ps]: large, medium, and small; HDL particles [HDL-Ps]: large, medium, and small). SSB consumption was estimated from food frequency questionnaire data. We examined the associations between SSB consumption and all lipoprotein and apoprotein measures in linear regression models, adjusting for confounding factors such as lifestyle, diet, and traditional lipoprotein risk factors. SSB consumption was positively associated with LDL cholesterol, apoB, TG, RLP-TG, RLP-C, and non-HDL cholesterol concentrations and total cholesterol:HDL cholesterol and apoB:apoA1 ratios; and negatively associated with HDL cholesterol and apoA1 concentrations (P-trend range: &lt;0.0001 to 0.008). After adjustment for traditional lipoprotein risk factors, SSB consumers had smaller LDL-P and HDL-P sizes; lower concentrations of large LDL-Ps and medium HDL-Ps; and higher concentrations of small LDL-Ps, small HDL-Ps, and large TRL-Ps (P-trend range: &lt;0.0001 to 0.001). Higher SSB consumption was associated with multiple emerging features of dyslipidemia that have been linked to higher cardiometabolic risk in US adults.</description><identifier>EISSN: 1541-6100</identifier><identifier>DOI: 10.1093/jn/nxac166</identifier><identifier>PMID: 36774119</identifier><language>eng</language><publisher>United States</publisher><subject>Adult ; Apolipoproteins ; Apolipoproteins B ; Cholesterol ; Cholesterol, HDL ; Cholesterol, LDL ; Dyslipidemias ; Female ; Humans ; Lipoproteins ; Male ; Particle Size ; Prospective Studies ; Sugar-Sweetened Beverages ; Triglycerides</subject><ispartof>The Journal of nutrition, 2022-11, Vol.152 (11), p.2534</ispartof><rights>Copyright © 2022 American Society for Nutrition.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36774119$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Haslam, Danielle E</creatorcontrib><creatorcontrib>Chasman, Daniel I</creatorcontrib><creatorcontrib>Peloso, Gina M</creatorcontrib><creatorcontrib>Herman, Mark A</creatorcontrib><creatorcontrib>Dupuis, Josée</creatorcontrib><creatorcontrib>Lichtenstein, Alice H</creatorcontrib><creatorcontrib>Smith, Caren E</creatorcontrib><creatorcontrib>Ridker, Paul M</creatorcontrib><creatorcontrib>Jacques, Paul F</creatorcontrib><creatorcontrib>Mora, Samia</creatorcontrib><creatorcontrib>McKeown, Nicola M</creatorcontrib><title>Sugar-Sweetened Beverage Consumption and Plasma Lipoprotein Cholesterol, Apolipoprotein, and Lipoprotein Particle Size Concentrations in US Adults</title><title>The Journal of nutrition</title><addtitle>J Nutr</addtitle><description>Prospective cohort studies have found a relation between sugar-sweetened beverage (SSB) consumption (sodas and fruit drinks) and dyslipidemia. There is limited evidence linking SSB consumption to emerging features of dyslipidemia, which can be characterized by variation in lipoprotein particle size, remnant-like particle (RLP), and apolipoprotein concentrations. To examine the association between SSB consumption and plasma lipoprotein cholesterol, apolipoprotein, and lipoprotein particle size concentrations among US adults. We examined participants from the Framingham Offspring Study (FOS; 1987-1995, n = 3047) and the Women's Health Study (1992, n = 26,218). Concentrations of plasma LDL cholesterol, apolipoprotein B (apoB), HDL cholesterol, apolipoprotein A1 (apoA1), triglyceride (TG), and non-HDL cholesterol, as well as total cholesterol:HDL cholesterol ratio and apoB:apoA1 ratio, were quantified in both cohorts; concentrations of apolipoprotein E, apolipoprotein C3, RLP-TG, and RLP cholesterol (RLP-C) were measured in the FOS only. Lipoprotein particle sizes were calculated from nuclear magnetic resonance signals for lipoprotein particle subclass concentrations (TG-rich lipoprotein particles [TRL-Ps]: very large, large, medium, small, and very small; LDL particles [LDL-Ps]: large, medium, and small; HDL particles [HDL-Ps]: large, medium, and small). SSB consumption was estimated from food frequency questionnaire data. We examined the associations between SSB consumption and all lipoprotein and apoprotein measures in linear regression models, adjusting for confounding factors such as lifestyle, diet, and traditional lipoprotein risk factors. SSB consumption was positively associated with LDL cholesterol, apoB, TG, RLP-TG, RLP-C, and non-HDL cholesterol concentrations and total cholesterol:HDL cholesterol and apoB:apoA1 ratios; and negatively associated with HDL cholesterol and apoA1 concentrations (P-trend range: &lt;0.0001 to 0.008). After adjustment for traditional lipoprotein risk factors, SSB consumers had smaller LDL-P and HDL-P sizes; lower concentrations of large LDL-Ps and medium HDL-Ps; and higher concentrations of small LDL-Ps, small HDL-Ps, and large TRL-Ps (P-trend range: &lt;0.0001 to 0.001). Higher SSB consumption was associated with multiple emerging features of dyslipidemia that have been linked to higher cardiometabolic risk in US adults.</description><subject>Adult</subject><subject>Apolipoproteins</subject><subject>Apolipoproteins B</subject><subject>Cholesterol</subject><subject>Cholesterol, HDL</subject><subject>Cholesterol, LDL</subject><subject>Dyslipidemias</subject><subject>Female</subject><subject>Humans</subject><subject>Lipoproteins</subject><subject>Male</subject><subject>Particle Size</subject><subject>Prospective Studies</subject><subject>Sugar-Sweetened Beverages</subject><subject>Triglycerides</subject><issn>1541-6100</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNkEtOwzAYhC0kREthwwGQD9BQOw8nXpaIAlIlKoWuKyf-U1I5tmU7vI7BiSkFBKtZzMwnzSB0QckVJTyZ7fRMv4qGMnaExjRLacQoISN06v2OEEJTXpygUcLyPKWUj9FHNWyFi6oXgAAaJL6GZ3BiC7g02g-9DZ3RWGiJV0r4XuBlZ411JkCncflkFPgAzqgpnluj_rzpofM_vBIudI0CXHXvB3oDOjjxxfd4768rPJeDCv4MHbdCeTj_0QlaL24ey7to-XB7X86XkaWkCFEti1YAYzXdT4klZW0NkosY4jzjedPQOE-KOuHAa0JbkmaZZC2Jc0k4ZzJrkgm6_Obaoe5BbqzreuHeNr_nJJ9SImgD</recordid><startdate>20221109</startdate><enddate>20221109</enddate><creator>Haslam, Danielle E</creator><creator>Chasman, Daniel I</creator><creator>Peloso, Gina M</creator><creator>Herman, Mark A</creator><creator>Dupuis, Josée</creator><creator>Lichtenstein, Alice H</creator><creator>Smith, Caren E</creator><creator>Ridker, Paul M</creator><creator>Jacques, Paul F</creator><creator>Mora, Samia</creator><creator>McKeown, Nicola M</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>20221109</creationdate><title>Sugar-Sweetened Beverage Consumption and Plasma Lipoprotein Cholesterol, Apolipoprotein, and Lipoprotein Particle Size Concentrations in US Adults</title><author>Haslam, Danielle E ; Chasman, Daniel I ; Peloso, Gina M ; Herman, Mark A ; Dupuis, Josée ; Lichtenstein, Alice H ; Smith, Caren E ; Ridker, Paul M ; Jacques, Paul F ; Mora, Samia ; McKeown, Nicola M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p108t-bd8fae66b17412d16fbed9a2e27597cc12738b39e9b01f0455d6f027d0996d5c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Adult</topic><topic>Apolipoproteins</topic><topic>Apolipoproteins B</topic><topic>Cholesterol</topic><topic>Cholesterol, HDL</topic><topic>Cholesterol, LDL</topic><topic>Dyslipidemias</topic><topic>Female</topic><topic>Humans</topic><topic>Lipoproteins</topic><topic>Male</topic><topic>Particle Size</topic><topic>Prospective Studies</topic><topic>Sugar-Sweetened Beverages</topic><topic>Triglycerides</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Haslam, Danielle E</creatorcontrib><creatorcontrib>Chasman, Daniel I</creatorcontrib><creatorcontrib>Peloso, Gina M</creatorcontrib><creatorcontrib>Herman, Mark A</creatorcontrib><creatorcontrib>Dupuis, Josée</creatorcontrib><creatorcontrib>Lichtenstein, Alice H</creatorcontrib><creatorcontrib>Smith, Caren E</creatorcontrib><creatorcontrib>Ridker, Paul M</creatorcontrib><creatorcontrib>Jacques, Paul F</creatorcontrib><creatorcontrib>Mora, Samia</creatorcontrib><creatorcontrib>McKeown, Nicola M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>The Journal of nutrition</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Haslam, Danielle E</au><au>Chasman, Daniel I</au><au>Peloso, Gina M</au><au>Herman, Mark A</au><au>Dupuis, Josée</au><au>Lichtenstein, Alice H</au><au>Smith, Caren E</au><au>Ridker, Paul M</au><au>Jacques, Paul F</au><au>Mora, Samia</au><au>McKeown, Nicola M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sugar-Sweetened Beverage Consumption and Plasma Lipoprotein Cholesterol, Apolipoprotein, and Lipoprotein Particle Size Concentrations in US Adults</atitle><jtitle>The Journal of nutrition</jtitle><addtitle>J Nutr</addtitle><date>2022-11-09</date><risdate>2022</risdate><volume>152</volume><issue>11</issue><spage>2534</spage><pages>2534-</pages><eissn>1541-6100</eissn><abstract>Prospective cohort studies have found a relation between sugar-sweetened beverage (SSB) consumption (sodas and fruit drinks) and dyslipidemia. There is limited evidence linking SSB consumption to emerging features of dyslipidemia, which can be characterized by variation in lipoprotein particle size, remnant-like particle (RLP), and apolipoprotein concentrations. To examine the association between SSB consumption and plasma lipoprotein cholesterol, apolipoprotein, and lipoprotein particle size concentrations among US adults. We examined participants from the Framingham Offspring Study (FOS; 1987-1995, n = 3047) and the Women's Health Study (1992, n = 26,218). Concentrations of plasma LDL cholesterol, apolipoprotein B (apoB), HDL cholesterol, apolipoprotein A1 (apoA1), triglyceride (TG), and non-HDL cholesterol, as well as total cholesterol:HDL cholesterol ratio and apoB:apoA1 ratio, were quantified in both cohorts; concentrations of apolipoprotein E, apolipoprotein C3, RLP-TG, and RLP cholesterol (RLP-C) were measured in the FOS only. Lipoprotein particle sizes were calculated from nuclear magnetic resonance signals for lipoprotein particle subclass concentrations (TG-rich lipoprotein particles [TRL-Ps]: very large, large, medium, small, and very small; LDL particles [LDL-Ps]: large, medium, and small; HDL particles [HDL-Ps]: large, medium, and small). SSB consumption was estimated from food frequency questionnaire data. We examined the associations between SSB consumption and all lipoprotein and apoprotein measures in linear regression models, adjusting for confounding factors such as lifestyle, diet, and traditional lipoprotein risk factors. SSB consumption was positively associated with LDL cholesterol, apoB, TG, RLP-TG, RLP-C, and non-HDL cholesterol concentrations and total cholesterol:HDL cholesterol and apoB:apoA1 ratios; and negatively associated with HDL cholesterol and apoA1 concentrations (P-trend range: &lt;0.0001 to 0.008). After adjustment for traditional lipoprotein risk factors, SSB consumers had smaller LDL-P and HDL-P sizes; lower concentrations of large LDL-Ps and medium HDL-Ps; and higher concentrations of small LDL-Ps, small HDL-Ps, and large TRL-Ps (P-trend range: &lt;0.0001 to 0.001). Higher SSB consumption was associated with multiple emerging features of dyslipidemia that have been linked to higher cardiometabolic risk in US adults.</abstract><cop>United States</cop><pmid>36774119</pmid><doi>10.1093/jn/nxac166</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier EISSN: 1541-6100
ispartof The Journal of nutrition, 2022-11, Vol.152 (11), p.2534
issn 1541-6100
language eng
recordid cdi_pubmed_primary_36774119
source MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Adult
Apolipoproteins
Apolipoproteins B
Cholesterol
Cholesterol, HDL
Cholesterol, LDL
Dyslipidemias
Female
Humans
Lipoproteins
Male
Particle Size
Prospective Studies
Sugar-Sweetened Beverages
Triglycerides
title Sugar-Sweetened Beverage Consumption and Plasma Lipoprotein Cholesterol, Apolipoprotein, and Lipoprotein Particle Size Concentrations in US Adults
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T23%3A11%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sugar-Sweetened%20Beverage%20Consumption%20and%20Plasma%20Lipoprotein%20Cholesterol,%20Apolipoprotein,%20and%20Lipoprotein%20Particle%20Size%20Concentrations%20in%20US%20Adults&rft.jtitle=The%20Journal%20of%20nutrition&rft.au=Haslam,%20Danielle%20E&rft.date=2022-11-09&rft.volume=152&rft.issue=11&rft.spage=2534&rft.pages=2534-&rft.eissn=1541-6100&rft_id=info:doi/10.1093/jn/nxac166&rft_dat=%3Cpubmed%3E36774119%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/36774119&rfr_iscdi=true